Home page539523 • BOM
add
Alkem Laboratories Ltd
Chiusura precedente
4723,95 ₹
Intervallo giornaliero
4609,50 ₹ - 4752,90 ₹
Intervallo annuale
4409,90 ₹ - 6440,00 ₹
Cap di mercato
553,45 Mld INR
Volume medio
3588,00
Rapporto P/E
25,73
Dividendo/Prezzo
0,91%
Borsa valori principale
NSE
Notizie
Dati finanziari
Conto economico
Entrate
Utile netto
(INR) | dic 2024info | Variazione Y/Y |
---|---|---|
Entrate | 33,74 Mld | 1,52% |
Spese di gestione | 14,96 Mld | 8,29% |
Utile netto | 6,26 Mld | 5,19% |
Margine di profitto netto | 18,55 | 3,63% |
Utili per azione | 52,34 | -2,59% |
EBITDA | 7,39 Mld | 4,74% |
Aliquota fiscale effettiva | 12,35% | — |
Stato patrimoniale
Totale attivo
Totale passivo
(INR) | dic 2024info | Variazione Y/Y |
---|---|---|
Investimenti cash/breve termine | 22,89 Mld | -36,59% |
Totale attivo | — | — |
Totale passivo | — | — |
Patrimonio netto totale | 119,10 Mld | — |
Azioni in circolazione | 119,57 Mln | — |
Prezzo/valore contabile | 4,91 | — |
Redditività dell'attivo | — | — |
Rendimento sul capitale | 12,59% | — |
Flusso di cassa
Flusso di cassa netto
(INR) | dic 2024info | Variazione Y/Y |
---|---|---|
Utile netto | 6,26 Mld | 5,19% |
Liquidità di esercizio | — | — |
Contanti da investimenti | — | — |
Contanti da finanziamenti | — | — |
Flusso di cassa netto | — | — |
Flusso di cassa libero | — | — |
Informazioni
Alkem Laboratories Limited is a leading Indian multinational pharmaceutical company headquartered in Mumbai, India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets a diverse portfolio of pharmaceutical generics, formulations and nutraceuticals across India and global markets.
With over five decades of expertise in the pharmaceutical industry, Alkem's journey began with a vision to transform India's healthcare landscape. Today, the company has established its presence in over 40 countries, operating 19 state-of-the-art manufacturing facilities and driving innovation through a team of 500+ scientists. Backed by a robust portfolio of 800+ brands, Alkem continues to set industry benchmarks in research, development, and manufacturing excellence.
Alkem primarily focuses on developing medications for a wide range of therapeutic areas, including infectious diseases, gastrointestinal disorders, pain management, gynecological conditions, pediatrics, osteoporosis, arthritis, cardiovascular diseases, diabetes, and several other critical health concerns. Wikipedia
Fondazione
1973
Sito web
Dipendenti
17.432